Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 10 December 2008, doi:10.1136/bmj.a2914
Cite this as: BMJ 2008;337:a2914
| The first 100% of the full text of this article appears below. |
Stewart and colleagues report their problems in applying for research approval.1 I easily trump their delay of one year.
For a randomised trial of general versus regional anaesthesia for hip fracture surgery, we first sought the approval of the Medicines and Healthcare products Regulatory Agency (MHRA). We applied in November 2004, and in October 2005 received a reply stating that MHRA approval was not necessary. Ethics approval was sought in October 2005 and granted in February 2007. The research and development application was made in February 2007 and approved in June 2007. The study started in June 2007. Total time for regulatory approval two years eight months.
Cite this as: BMJ 2008;337:a2914
Martyn Parker, orthopaedic research fellow1
1 Orthopaedic Department, Peterborough District Hospital, Peterborough PE3 6DA
martyn.parker@pbh-tr.nhs.uk